224 related articles for article (PubMed ID: 19828637)
61. Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
Gragnani L; Piluso A; Urraro T; Fabbrizzi A; Fognani E; Petraccia L; Genovesi A; Giubilei L; Ranieri J; Stasi C; Monti M; Zignego AL
Curr Drug Targets; 2017; 18(7):772-785. PubMed ID: 26853322
[TBL] [Abstract][Full Text] [Related]
62. Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection.
Buezo GF; García-Buey M; Rios-Buceta L; Borque MJ; Aragües M; Daudén E
Int J Dermatol; 1996 Feb; 35(2):112-5. PubMed ID: 8850039
[TBL] [Abstract][Full Text] [Related]
63. Anti-Clq antibodies in patients with chronic hepatitis C infection.
Lienesch DW; Sherman KE; Metzger A; Shen GQ
Clin Exp Rheumatol; 2006; 24(2):183-5. PubMed ID: 16762156
[TBL] [Abstract][Full Text] [Related]
64. HCV-RNA detection using different PCR methods in sera, cryoglobulins and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia.
de Maddalena C; Zehender G; Bianchi Bosisio A; Monti G; Monteverde A; Invernizzi F; Galli M
Clin Exp Rheumatol; 1995; 13 Suppl 13():S119-22. PubMed ID: 8730491
[TBL] [Abstract][Full Text] [Related]
65. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
66. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
Schott P; Hartmann H; Ramadori G
Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
[TBL] [Abstract][Full Text] [Related]
67. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
68. Human C1q induces eosinophil migration.
Kuna P; Iyer M; Peerschke EI; Kaplan AP; Reid KB; Ghebrehiwet B
Clin Immunol Immunopathol; 1996 Oct; 81(1):48-54. PubMed ID: 8808641
[TBL] [Abstract][Full Text] [Related]
69. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
[TBL] [Abstract][Full Text] [Related]
70. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
[TBL] [Abstract][Full Text] [Related]
71. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway.
Yao ZQ; Nguyen DT; Hiotellis AI; Hahn YS
J Immunol; 2001 Nov; 167(9):5264-72. PubMed ID: 11673541
[TBL] [Abstract][Full Text] [Related]
72. Analysis of complement-bound HCV complexes using a novel immuno-capture RT-PCR method.
Zhu H; Wang SY; Zhang JY; Lian QZ; Peng XX
Scand J Immunol; 2002 Nov; 56(5):538-42. PubMed ID: 12410805
[TBL] [Abstract][Full Text] [Related]
73. [Serum CXCL-10 level in chronic hepatitis C patients with cryoglobulinemia and its influence on antiviral therapy].
Fan XH; Deng ZH; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):744-748. PubMed ID: 27938559
[No Abstract] [Full Text] [Related]
74. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis.
Ghebrehiwet B; Kew RR; Gruber BL; Marchese MJ; Peerschke EI; Reid KB
J Immunol; 1995 Sep; 155(5):2614-9. PubMed ID: 7650391
[TBL] [Abstract][Full Text] [Related]
75. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
[TBL] [Abstract][Full Text] [Related]
76. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
77. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading.
Feng X; Tonnesen MG; Peerschke EI; Ghebrehiwet B
J Immunol; 2002 Mar; 168(5):2441-8. PubMed ID: 11859136
[TBL] [Abstract][Full Text] [Related]
78. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
79. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection.
Ghebrehiwet B; Peerschke EI
Mol Immunol; 2004 Jun; 41(2-3):173-83. PubMed ID: 15159063
[TBL] [Abstract][Full Text] [Related]
80. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
